Ghent University Academic Bibliography

Your filters: cql: keyword exact "ART-175"

Add to list
- Journal Article
- A1
- open access
Distinct mode of action of a highly stable, engineered phage lysin killing Gram-negative bacteria

Hans Gerstmans, Lisa Duyvejonck (UGent) , Roberto Vázquez (UGent) , Ines Staes, Jimmy Borloo (UGent) , Karim Abdelkader Soufi Abdelkader, Jeroen Leroy, Emma Cremelie (UGent) , Diana Gutierrez Fernandez (UGent) , Héctor Tamés-Caunedo, et al.

(2023) MICROBIOLOGY SPECTRUM. 11(6).
Add to list
- Journal Article
- A1
- open access
Phages and engineered lysins as an effective tool to combat Gram-negative foodborne pathogens

Aleksandra Maria Kocot, Yves Briers (UGent) and Magdalena Plotka

(2023) COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY. 22(3). p.2235-2266
Add to list
- Journal Article
- A1
- open access
Engineering a lysin with intrinsic antibacterial activity (LysMK34) by cecropin a fusion enhances its antibacterial properties against acinetobacter baumannii

Karim Abdelkader Soufi Abdelkader, Diana Gutierrez Fernandez (UGent) , Héctor Tamés-Caunedo, Patricia Ruas-Madiedo, Amal Safaan, Ahmed S. Khairalla, Yasser Gaber, Tarek Dishisha and Yves Briers (UGent)

(2022) APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 88(1).
Add to list
Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go

Diana Gutierrez Fernandez (UGent) and Yves Briers (UGent)

(2021) CURRENT OPINION IN BIOTECHNOLOGY. 68. p.15-22
Add to list
- Journal Article
- A1
- open access
A VersaTile driven platform for rapid hit-to-lead development of engineered lysins

Hans Gerstmans, Dennis Grimon (UGent) , Diana Gutierrez Fernandez (UGent) , Cédric Lood, Ana Rodríguez, Vera van Noort, Jeroen Lammertyn, Rob Lavigne and Yves Briers (UGent)

(2020) SCIENCE ADVANCES. 6(23).
Add to list
- Journal Article
- A1
Breaking barriers : expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria

Yves Briers (UGent) and Rob Lavigne

(2015) FUTURE MICROBIOLOGY. 10(3). p.377-390

Academic Bibliography

Distinct mode of action of a highly stable, engineered phage lysin killing Gram-negative bacteria

Phages and engineered lysins as an effective tool to combat Gram-negative foodborne pathogens

Engineering a lysin with intrinsic antibacterial activity (LysMK34) by cecropin a fusion enhances its antibacterial properties against acinetobacter baumannii

Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go

A VersaTile driven platform for rapid hit-to-lead development of engineered lysins

Breaking barriers : expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria

Contents

Support

Contact